Shares of Chembio Diagnostics (CEMI +4.2%) moves higher after the USDA approves its CervidTB...

|About: Chembio Diagnostics, Inc. (CEMI)|By:, SA News Editor

Shares of Chembio Diagnostics (CEMI +4.2%) moves higher after the USDA approves its CervidTB STAT-PAK and DPP VetTB test kits as primary and secondary tests for bovine tuberculosis by the USDA Animal and Plant Health Inspection Service. The approval was made in order to provide the farmed deer industry with more options for meeting testing requirements for captive elk and deer.